A detailed history of Mcdaniel Terry & CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Mcdaniel Terry & CO holds 1,795 shares of LLY stock, worth $1.57 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,795
Previous 795 125.79%
Holding current value
$1.57 Million
Previous $704,000 96.88%
% of portfolio
0.11%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$727.2 - $932.06 $727,200 - $932,060
1,000 Added 125.79%
1,795 $1.39 Million
Q3 2024

Oct 23, 2024

BUY
$772.14 - $960.02 $252,489 - $313,926
327 Added 69.87%
795 $704,000
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $121,778 - $152,718
-168 Reduced 26.42%
468 $424,000
Q1 2024

Apr 29, 2024

BUY
$592.2 - $792.28 $118,440 - $158,456
200 Added 45.87%
636 $495,000
Q2 2023

Jul 21, 2023

BUY
$350.74 - $468.98 $152,922 - $204,475
436 New
436 $204,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $830B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mcdaniel Terry & CO Portfolio

Follow Mcdaniel Terry & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcdaniel Terry & CO, based on Form 13F filings with the SEC.

News

Stay updated on Mcdaniel Terry & CO with notifications on news.